2024-11-08  8:05:11 AM Chg. +5.000 Volume Bid10:00:01 PM Ask10:00:01 PM Market Capitalization Dividend Y. P/E Ratio
228.100EUR +2.24% 0
Turnover: 0.000
-Bid Size: - -Ask Size: - 17.54 bill.EUR - -

Business description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager.
 

Management board & Supervisory board

CEO
Jim Hollingshead
Management board
Wayde McMillan, Eric Benjamin, Lauren Budden, Laetitia Cousin, Patrick Crannell, Mark Field, Deborah Gordon, John Kapples, Dr. Trang Ly, Dan Manea, Prem Singh
Supervisory board
Luciana Borio, Wayne A. I. Frederick, Jim Hollingshead, Jessica Hopfield, Michael R. Minogue, Corinne Nevinny, Shacey Petrovic, Timothy J. Scannell, Elizabeth Weatherman
 

Company data

Name: Insulet Corporation
Address: 100 Nagog Park,Acton, MA 01720
Phone: (+1) 978-600-7000
Fax: (+1) 978-600-0120
E-mail: -
Internet: https://www.insulet.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: -
End of financial year: 12-31
Free Float: -
IPO date: 2007-05-15

Investor relations

Name: Deborah R. Gordon
IR phone: -
IR Fax: -
IR e-mail: ir@insulet.com

Main Shareholders